Compounds, compositions and methods of inhibiting a-synuclein toxicity

Details for Australian Patent Application No. 2005287137 (hide)

Owner Whitehead Institute for Biomedical Research FoldRx Pharmaceuticals, Inc.

Inventors Outeiro, Tiago; Labaudiniere, Richard; Lindquist, Susan L.

Agent Cullens

Pub. Number AU-B-2005287137

PCT Pub. Number WO2006/034003

Priority 60/610,796 17.09.04 US

Filing date 16 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 22 March 2012

International Classifications

A61K 31/425 (2006.01) - Thiazoles

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/522 (2006.01)

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/034003 Priority application(s): WO2006/034003

22 March 2012 Application Accepted

  Published as AU-B-2005287137

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287139-Treatment of bone disorders with skeletal anabolic drugs

2005287122-Glyphosate formulations with early burndown symptoms